Garrison Point Advisors, LLC Bristol Myers Squibb CO Transaction History

Garrison Point Advisors, LLC

$205 Million
Q1 2025

A detailed history of Garrison Point Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Garrison Point Advisors, LLC holds 16,531 shares of BMY stock, worth $794,975. This represents 0.49% of its overall portfolio holdings.

Number of Shares

16,531

Previous 16,331 1.22%

Holding current value

$794,975

Previous $923,000 9.21%

% of portfolio

0.49%

Previous 0.44%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$53.9 - $63.11 $10,780 - $12,622	200 Added 1.22%	16,531 $1.01 Million
Q3 2024 Oct 23, 2024	SELL	$39.66 - $51.75 $21,218 - $27,686	-535 Reduced 3.17%	16,331 $845,000
Q2 2024 Aug 07, 2024	SELL	$40.25 - $52.99 $24,311 - $32,005	-604 Reduced 3.46%	16,866 $700,000
Q1 2024 May 09, 2024	SELL	$47.98 - $54.4 $19,192 - $21,760	-400 Reduced 2.24%	17,470 $947,000
Q4 2023 Feb 08, 2024	SELL	$48.48 - $57.85 $19,682 - $23,487	-406 Reduced 2.22%	17,870 $916,000
Q3 2023 Oct 17, 2023	SELL	$57.89 - $64.73 $11,809 - $13,204	-204 Reduced 1.1%	18,276 $1.06 Million
Q2 2023 Jul 25, 2023	SELL	$63.71 - $70.74 $8,282 - $9,196	-130 Reduced 0.7%	18,480 $1.18 Million
Q1 2023 May 05, 2023	SELL	$65.71 - $74.53 $1,708 - $1,937	-26 Reduced 0.14%	18,610 $1.29 Million
Q2 2022 Aug 10, 2022	BUY	$72.62 - $79.98 $7,262 - $7,998	100 Added 0.54%	18,636 $1.44 Million
Q3 2021 Nov 04, 2021	BUY	$59.17 - $69.31 $7,100 - $8,317	120 Added 0.65%	18,536 $1.1 Million
Q2 2021 Aug 02, 2021	BUY	$61.91 - $67.42 $6,562 - $7,146	106 Added 0.58%	18,416 $1.23 Million
Q1 2021 May 04, 2021	SELL	$59.34 - $66.74 $4,153 - $4,671	-70 Reduced 0.38%	18,310 $1.16 Million
Q4 2020 Jan 28, 2021	BUY	$57.74 - $65.43 $28,003 - $31,733	485 Added 2.71%	18,380 $1.14 Million
Q3 2020 Oct 27, 2020	SELL	$57.43 - $63.64 $5,743 - $6,364	-100 Reduced 0.56%	17,895 $1.08 Million
Q2 2020 Aug 03, 2020	SELL	$54.82 - $64.09 $26,203 - $30,635	-478 Reduced 2.59%	17,995 $1.06 Million
Q1 2020 Apr 20, 2020	SELL	$46.4 - $67.43 $21,761 - $31,624	-469 Reduced 2.48%	18,473 $1.03 Million
Q4 2019 Jan 24, 2020	BUY	$49.21 - $64.19 $323,063 - $421,407	6,565 Added 53.04%	18,942 $1.22 Million
Q4 2018 Feb 11, 2019	BUY	$48.76 - $63.23 $603,502 - $782,597	12,377 New	12,377 $643,000

Others Institutions Holding BMY

# of Institutions

2,810

Shares Held

1.59B

Call Options Held

25.9M

Put Options Held

23.9M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $102B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Garrison Point Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Garrison Point Advisors, LLC with notifications on news.

Account

Garrison Point Advisors, LLC Bristol Myers Squibb CO Transaction History